As J&J Shot Resumes, Polling Seen as Key to ‘Arm the Messengers’

More extensive polling on people’s perception of Covid-19 vaccines will be crucial to tailoring public health officials’ messaging after U.S. agencies lifted a recommended pause on the Johnson & Johnson shot, researchers say.

The Food and Drug Administration and Centers for Disease Control and Prevention said April 23 that health providers should resume administering the J&J vaccine after it was paused 10 days earlier, and they issued a revised fact sheet for providers with information about the risk of rare blood clots. The decision followed reports of 15 people developing clots after getting vaccinated—more than double the cases that prompted ...